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A B S T R A C T
Advances in medical technology and the health sciences have lead to a rapid increase in the prevalence and morbidity
of high-risk infants with chronic or permanent sequels such as the birth of early preterm infants. A suitable formula is
therefore needed for body surface area (BSA) estimation for high-risk infants to more accurately devise therapeutic re-
gimes in clinical practice. A cohort study involving 5014 high-risk infants was conducted to develop a suitable formula
for estimating BSA using four of the existing formulas in the literature. BSA of high-risk infants was calculated using
the four BSA equations (Boyd-BSA, Dubois-BSA, Meban-BSA, Mosteller-BSA), from which a new calculation, Mean-
-BSA, was arithmetically derived as a reference BSA measure. Multiple-regression was performed using nonlinear least
squares curve fitting corresponding to the trend line and the new equation, Neo-BSA, developed using Excel and SPSS
17.0. The Neo-BSA equation was constructed as follows: Neo-BSA=5.520xW0.5526xL0.3800. With the assumption of the
least square root relation between weight and length, a BSA scale using only weight was fabricated specifically for clini-
cal applications where weight is more available in high-risk infant populations than is length. The validity of Neo-BSA
was evaluated against Meban-BSA, the best of the four equations for high-risk infants, as there is a similarity of subjects
in the two studies. The other formulas revealed substantial variances in BSA compared to Neo-BSA. This study devel-
oped a new surface area equation, Neo-BSA, as the most suitable formula for BSA measurement of high-risk infants in
modern-day societies, where an emerging population of newborns with shorten gestational ages are becoming more prev-
alent as a result of new advances in the health sciences and new development of reproductive technologies. In particular,
a scale for 400–7000 g body weight babies derived from the Neo-BSA equation has the clinical advantage of using only
weight as a measurement, since length is often not feasible as a measurement due to the newborn’s body posture. Further
studies are required to confirm our findings for the application of Neo-BSA and the BSA scale (based on weight) for vari-
ous populations and ethnicities under different clinical conditions.
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Introduction
Advances in medical technology and the health sci-
ences have led to a rapid decrease in mortality as well as
increases in the survival of high-risk infants that in-
cludes early preterm births. In Korea, the rate of preterm
births increased from 3.8% in 2000 to 15.7% in 20061 as
the rate of low birth weight (LBW) newborns delivered at
acute tertiary hospitals increased from 15% in the 1980s
to 25% in 20002. This increase in LBW is a world-wide
phenomenon of modern societies; in the United States,
the rate of preterm births was 9.3% in 1981 and 12.5% in
20063. Practicing health care professionals are being con-
fronted by a substantial challenge to develop medical
treatments and medical care protocols based on knowl-
edge of specific body structure and function of high-risk
infants. Body surface area (BSA) has become of signifi-
cant interest to child-health care specialists and scien-
tists for a variety of reasons, including the importance of
anthropometric size, body aerodynamics and hydrody-
namics1,4 and drug metabolism and chemotherapy5,6, with
special considerations for total body water composition7,
transdermal insensible water loss8, and thermoregula-
tion9 in high-risk infants.
Direct measurement of BSA of infants however, is not
feasible in most cases considering its dependence on in-
fant manipulation and use of multifaceted instruments,
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which increase energy consumption and expenditure in
high-risk babies, for whom energy conservation can be
vital to survival. As well, differences in geometric as-
sumptions of the infant body and limbs10,11 based on hu-
man life cycle variation, limits the application of the ex-
isting BSA formulas developed decades ago with little
consideration for biometric shapes of high-risk infants.
Given the significant variation in BSA estimation for
full-term infants using popular formulas11, the possibil-
ity that substantial errors are likely to occur in BSA esti-
mation of preterm births or LBW infants is significant.
Therefore, a study was undertaken to develop a more
suitable formula for BSA estimation in high-risk infants
including early preterm births and LBW babies that
more accurately reflects their body biometrics and are
more accurate for therapeutic use in clinical practice.
Materials and Methods
Participants
A cohort study was conducted to develop a suitable
formula for BSA estimates using existing formulas in
5014 high-risk infants hospitalized in a level III Neonatal
Intensive Care Unit (NICU) and nursery in two Korean
University affiliated hospitals. Both hospitals, located in
large urban areas, are national referral centers where
high-risk infants are delivered with various conditions
such as extremely LBW or early preterm births as early
as at 24 weeks gestation (gestation age, GA). All new-
borns at the two sites were enrolled from August 2007 to
July 2008. However, infants transferred from other hos-
pitals, or those with multigestational or congenital skele-
tal disorders were excluded from the study because of
their possible affect on BSA. The institutional review
board of the hospital approved the study. In the 5014 sub-
jects (54.6% male newborns), the mean GA was 37.8
weeks (range 23.5–42 weeks) with a mean body weight of
2994 g (range 480–6500 g) and a mean length of 49 cm
(range 21–60 cm). Within the infant cohort 1424 (28.4%)
were preterm births while 17 (0.3%) were post-term.
Study protocol
In order to develop a suitable formula for BSA estima-
tion of high-risk infants, the study design involved sev-
eral steps. First, using the existing BSA formulas as
listed below, four BSA calculations were performed. The-
se four formulas were selected based on their common
use in the literature12,13 or because they were derived us-
ing a pediatric sample, including stillborns14,15. Secondly,
the fifth formula is an arithmetic mean of the four for-
mulas below calculated as a Mean BSA, which can be
considered a best measure of BSA since the four formu-
las have all been derived in independent studies16. When
direct measurement of BSA (the ‘gold standard’) is not
possible the arithmetic mean of BSA can serve to accu-
rately reflect BSA based on any given formula11,17. Third,
variation in the four BSA formulas was evaluated aga-
inst the Mean-BSA as the reference BSA for each gesta-
tional age. Fourth, the trend line for Mean-BSA was gen-
erated with a goodness-of-fitness in weight and length
using a curve fitting model. Finally, the logarithm formu-
la was arithmetically formulated using nonlinear least
squares curve fitting corresponding to the trend line as a
suitable BSA formula called, Neo-BSA, specifically for
use among high-risk infants. In addition, with the as-
sumption of the least squares root relation between
weight and length, a BSA scale using only weight was de-
veloped for clinical practice where weight is more avail-
able compared to height for high-risk infants.
In order to minimize any influencing factors affecting
body biometrics such as the amount of food intake or
physiologic weight loss shortly after birth, birth weight
in kg (*except in g for the Meban formula), and birth
length (height) in cm were used for all calculation. Ex-
plorative data analysis with descriptive statistics, multi-
ple regression analysis using a curve fitting model and
logarithm function, ANOVA, and correlation was ac-












Weight, lenght, and percent growth for gestational
age
Table 1 shows the values for weight, length, and per-
cent of growth of preterm infants by gestational age were
calculated against the weight and length at 39–40 weeks
(full term gestation). Weight and length of infants born
at 24 weeks GA were 679 g and 31 cm respectively, corre-
sponding to 21% and 62% of full-term growth. Weight
reached up to 60% of full term growth, while height was
almost 90% after 34 weeks GA. Both weight and length
were positively correlated with GA (r=.752 and.773,
p=.000, respectively).
BSA measurements and its variation using
Mean-BSA
The BSA measurements using the four formulas abo-
ve and the Mean-BSA are shown for each GA in Table 2.
The smallest (725 cm2 at 24 weeks GA) and the largest
(2326 cm2 at 42 weeks GA) BSA calculations among all
measurements were produced by the Boyd-BSA. These
five BSA measurements revealed that at 24 weeks GA
about one-third and at 33 weeks GA about two thirds of
BSA is attained, compared to full term gestation at 39–40
weeks as shown in Table 3. Since Mean-BSA served as
the best reference BSA measurement, variations in per-
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centile of BSA measurements by the other four formulas
were examined against the Mean-BSA. As shown in Ta-
ble 4, there were significant differences in the four BSA
measurements for each GA (3.0886<F<16121.91, p<.039).
Figure 1 illustrates a significant difference in the pat-
terns of variation in BSA measurements by GA com-
pared to Mean-BSA. As GA increased, variation of Boyd-
-BSA increased, while those of Dubois-BSA decreased,
showing almost a 10% difference between the two mea-
sures (–5.1 to 5.1%) for full term gestation. Meban-BSA
and Mosteller-BSA provided relatively less variation com-
pared to Mean-BSA, which tended to decrease as GA in-
creased.
Development of Neo-BSA
Since weight and height are the major determinants
of BSA, curve estimation using the least squares meth-
ods in multiple regression was performed to reveal the
relationship of Mean-BSA to weight and length. As a re-
sult, the trend line was constructed with the highest cor-
relation coefficient between Mean-BSA and weight (Fig-
ure 2). Subsequently, a logarithm equation was formu-
lated based on goodness-of-fit of the trend line between
Mean-BSA and weight, which was named Neo-BSAw. The
same procedure was carried out for the equation for the
trend line between Mean-BSA and length, which was
named Neo-BSAh (Figure 3). These logarithm formulas
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TABLE 1
PERCENT OF FULL-TERM WEIGHT AND LENGTH OF PREMATURE INFANTS BY GESTATIONAL AGE (GA) AT BIRTH (N = 5014)
GA N (%)
Weight(gram) Length(cm) % of full-term Weight % of full-time Length (%)
X (SD) X (SD) X (SD) X (SD)
24 7 (0.1) 678.6 (84.90) 31.1 (1.17) 20.7 (2.58) 61.8 (2.32)
25 16 (0.3) 855.1 (478.97) 34.1 (4.48) 26.0 (14.57) 67.9 (8.91)
26 13 (0.3) 943.4 (396.29) 33.9 (6.08) 28.7 (12.06) 67.3 (12.08)
27 24 (0.5) 1009.6 (305.45) 35.2 (3.61) 30.7 (9.29) 67.0 (7.18)
28 34 (0.7) 1208.0 (366.77) 37.6 (3.38) 36.7 (11.16) 74.6 (6.72)
29 27 (0.5) 1338.2 (482.25) 38.5 (3.73) 40.7 (14.67) 76.5 (7.42)
30 49 (1.0) 1321.4 (342.27) 38.6 (3.54) 40.2 (10.41) 76.7 (7.04)
31 48 (1.0) 1623.5 (409.07) 40.9 (3.13) 49.4 (12.44) 81.4 (6.22)
32 59 (1.2) 1716.0 (297.77) 42.1 (0.06) 52.2 (9.06) 83.8 (6.09)
33 72 (1.4) 1871.1 (423.16) 43.4 (2.73) 56.9 (12.87) 86.2 (5.43)
34 105 (2.1) 2170.1 (372.67) 44.9 (2.87) 66.0 (11.34) 89.3 (5.70)
35 143 (2.9) 2331.9 (510.77) 45.6 (2.74) 70.9 (15.54) 90.7 (5.45)
36 241 (4.8) 2528.6 (471.80) 46.8 (2.65) 76.9 (14.35) 93.1 (5.28)
37 584 (11.6) 2833.7 (487.76) 48.3 (2.41) 86.2 (14.84) 96.0 (4.80)
38 1059 (21.1) 3105.3 (459.04) 49.4 (2.25) 94.5 (13.96) 98.1 (4.47)
39 1168 (23.3) 3241.8 (425.13) 50.0 (2.00) 98.6 (12.93) 99.5 (3.97)
40 976 (19.5) 3342.5 (429.90) 50.6 (2.16) 101.7 (13.08) 100.7 (4.29)
41 371 (7.4) 3446.6 (491.19) 51.1 (1.97) 104.8 (14.94) 101.7 (3.91)
42 17 (0.3) 3423.2 (393.61) 50.9 (1.82) 104.1 (11.97) 101.1 (3.62)
Total 5014 (100) 2994.3 (683.20) 48.9 (3.68) 91.1 (20.78) 97.1 (7.31)
Fig. 1. Percent variance in BSA measurements compared to the
Mean-BSA.
By taking the logarithm of both sides of above equa-
tion, the equation can be expressed as a linear relation-
ship. The log(BSA)-log(Weight)-log(Length) relationship
was investigated by applying multiple regression analy-
sis. Finally, the Neo-BSA formula using weight and len-
gth was constructed as follows:
Neo-BSA=5.52005´W0.5526´L0.3800
The lack of difference between Neo-BSA and Mean-
-BSA using a paired t-test (t=–.494, p=.621) and high
correlation between two measurements (r=.997, p=.000)
supported the validity of Neo-BSA against the reference
Mean-BSA. Meanwhile, similarity and dissimilarity of
the existing four formulas against Neo-BSA remains to
be explored, considering that the Neo-BSA was formu-
lated for the Mean-BSA, which was the mean of these
four formula measurements. Correlation coefficients and
Euclidean distance (ordinary distance between two points)
were analyzed for similarity and dissimilarity of BSA
measurements for the existing formulas compared to
Neo-BSA. As presented in Table 5, Neo-BSA showed an
almost perfect correlation with the other four formulas.
However, Boyd-BSA and Dubois-BSA showed relatively
substantial Euclidean distance against Neo-BSA, while
Meban-BSA and Mosteller-BSA showed the least Euclid-
ean distance (601.1 and 892.8 respectively). Therefore, in
a geometric sense, Neo-BSA corresponds much more to
Meban-BSA and Mosteller-BSA, while significant differ-
ences exist between Neo-BSA and Boyd-BSA and Du-
bois-BSA, irrespective of the similar patterns of BSA
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TABLE 2
BSA CALCULATION (in cm2) OF THE SAMPLE (N=5014) USING FOUR BSA FORMULAS AND THE CALCULATED MEAN-BSA
GA
Boyd-BSA Dubois-BSA Meban-BSA Mosteller-BSA Mean-BSA
X (SD) X (SD) X (SD) X (SD) X (SD)
24 724.8 (66.58) 761.0 (61.98) 761.0 (61.98) 765.1 (61.05) 746.7 (61.68)
25 840.5 (298.61) 861.6 (266.52) 879.4 (278.32) 889.2 (277.85) 867.6 (280.11)
26 907.7 (264.45) 885.7 (282.66) 914.9 (287.27) 919.9 (290.18) 912.0 (289.43)
27 960.6 (195.53) 947.7 (189.20) 980.0 (194.60) 984.9 (194.60) 966.7 (194.71)
28 1094.0 (216.08) 1065.7 (197.75) 1099.3 (211.48) 1115.8 (208.54) 1087.3 (212.39)
29 1171.7 (297.21) 1148.1 (247.2) 1194.2 (277.27) 1196.7 (267.79) 1181.8 (276.50)
30 1168.6 (205.21) 1140.3 (202.58) 1181.1 (209.67) 1185.9 (209.93) 1168.9 (211.44)
31 1355.2 (233.36) 1296.8 (205.70) 1349.3 (225.09) 1351.7 (219.70) 1337.8 (225.60)
32 1413.7 (179.10) 1343.9 (163.00) 1390.3 (168.55) 1396.3 (168.55) 1380.2 (169.93)
33 1501.2 (241.21) 1428.7 (185.21) 1479.0 (204.58) 1484.7 (198.81) 1469.6 (204,69)
34 1672.4 (209.00) 1577.8 (173.12) 1648.0 (181.78) 1647.6 (180.46) 1638.4 (183.16)
35 1757.4 (172.88) 1638.6 (213.35) 1716.0 (236.68) 1713.4 (229.69) 1706.6 (237.30)
36 1864.3 (246.27) 1729.4 (195.48) 1812.2 (213.62) 1809.8 (208.55) 1803.5 (214.57)
37 2022.4 (250.06) 1856.9 (192.00) 1952.6 (213.90) 1945.7 (206.90) 1944.6 (214.16)
38 2160.1 (228.18) 1960.7 (177.27) 2069.8 (197.32) 2058.7 (190.95) 2062.0 (197.89)
39 2227.2 (207.12) 2018.0 (157.59) 2131.6 (176.91) 2119.5 (170.40) 2124.3 (177.27)
40 2277.3 (208.30) 2060.5 (162.17) 2175.8 (178.36) 2164.1 (174.36) 2169.2 (179.32)
41 2325.6 (229.04) 2102.2 (167.68) 2219.2 (193.76) 2207.1 (184.17) 2213.1 (193.66)
42 2317.1 (188.15) 2090.4 (145.56) 2210.4 (161.35) 2196.76 (156.30) 2203.7 (162.01)
Total 2096.2 (359.02) 1917.6 (283.27) 2020.7 (310.11) 2011.6 (302.78) 2013.1 (311.41)
GA: gestational age in weeks; BSA: body surface area
Fig. 2. Trend line of BSA by weight. Fig. 3. Trend line of BSA by length.
measurement using these formulas. In addition, in order
to develop a clinically feasible BSA scale, length was
transformed into weight with the assumption of the
square root relation between the two, and a logarithm
equation for BSA measurement was fabricated using
only weight. Figure 4 illustrates the scale for BSA mea-
surements using only weight (400–7000 g), which could
be implemented as a bedside use for high-risk infants.
Discussion and Conclusion
Although estimating the BSA of high-risk infants is of
significant interest to health professionals especially con-
sidering its applications in therapeutic regimens, there is
a paucity of proper methods for these fragile high-risk
populations. This study developed a BSA formula (Neo-
-BSA) that can be used for all infants, including ex-
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TABLE 3
PERCENT CHANGE IN BSA BY GESTATIOAL WEEK FOR THE FIVE FORMULAS
GA
Boyd-BSA Dubois-BSA Meban-BSA Mosteller-BSA Mean-BSA
X (SD) X (SD) X (SD) X (SD) X (SD)
24 32.2 (2.96) 36.1 (2.82) 35.4 (2.88) 35.8 (2.85) 34.8 (2.88)
25 37.3 (13.27) 42.3 (13.08) 40.9 (12.94) 41.6 (12.99) 40.5 (13.06)
26 40.3 (11.75) 43.5 (13.87) 42.5 (13.35) 43.0 (13.56) 42.1 (13.50)
27 42.7 (8.69) 46.5 (9.29) 45.5 (8.97) 46.0 (9.10) 45.1 (9.08)
28 48.6 (9.60) 52.3 (9.71) 51.1 (9.83) 51.7 (9.75) 50.7 (9.90)
29 52.1 (13.21) 56.3 (12.13) 55.5 (12.89) 55.9 (12.52) 55.1 (12.89)
30 51.9 (9.13) 56.0 (9.94) 54.9 (9.75) 55.4 (9.81) 54.5 (9.86)
31 60.2 (10.37) 63.6 (11.00) 62.7 (10.46) 63.2 (10.27) 62.4 (10.52)
32 62.8 (7.96) 66.0 (8.00) 64.6 (7.84) 65.3 (7.88) 64.4 (7.92)
33 66.7 (10.72) 70.1 (9.09) 68.7 (9.51) 69.4 (9.29) 68.5 (9.54)
34 74.3 (9.29) 77.4 (8.50) 76.6 (8.45) 77.0 (8.43) 76.4 (8.54)
35 78.1 (12.13) 80.4 (10.47) 79.8 (11.00) 80.1 (10.73) 79.6 (11.06)
36 82.8 (10.94) 84.9 (9.59) 84.2 (9.92) 84.5 (9.75) 84.1 (10.01)
37 89.9 (11.11) 91.1 (9.42) 90.8 (9.93) 90.9 (9.67) 90.7 (9.99)
38 96.0 (10.14) 96.2 (8.70) 96.2 (9.17) 96.2 (8.92) 96.2 (9.23)
39 99.0 (9.20) 99.0 (7.73) 99.1 (8.22) 99.1 (7.96) 99.1 (8.27)
40 101.2 (9.24) 101.3 (7.96) 101.1 (8.30) 101.1 (8.10) 101.1 (8.36)
41 103.4 (10.18) 103.2 (8.23) 103.1 (9.01) 103.2 (8.61) 103.2 (9.03)
42 103.0 (8.36) 102.6 (7.14) 102.7 (7.50) 102.7 (7.30) 102.8 (7.55)
Total 93.2 (15.95) 94.1 (13.90) 93.9 (14.41) 94.0 (14.15) 93.9 (14.52)
GA: gestational age in weeks; BSA: body surface area
Fig. 4. BSA scale using weight only for infants.
tremely LBW newborns. Also, a BSA scale was con-
structed that used only body weight, as length measure-
ments are often not feasible in most neonatal practices.
Neo-BSA revealed near-perfect correlations with Me-
ban-BSA and Mosteller-BSA, by showing a maximum
2.6% of variance, which decreased as GA increased (Fig-
ure 1). A high correlation was still observed with Boyd-
-BSA and Dubois-BSA, which are popular surface area
estimates for the general population. However, since a
correlation implies a similarity of pattern between two
parameters, a high correlation among BSA measure-
ments in this study is not unexpected, considering that
Neo-BSA was constructed from these four formulas. In
other words, regardless of a good correlation between
two measures, a systematic error could still exist, evi-
denced by Euclidian distance (Table 5), which may be
useful to compare the suitability of Neo-BSA with the
other formulas. In this study, the Euclidian distance was
shortest between Neo-BSA and Meban-BSA (601.1), fol-
lowed by Mosteller-BSA. The near-perfect correlation
and the smallest Euclidian distance between Neo-BSA
and Meban-BSA supports the overall validity as Neo-
-BSA as the best body surface estimate. This is consis-
tent with the previous report that found that Meban-
-BSA provides the best surface estimates by showing the
least variance (<3%) among several BSA measurements
in full term infants11.
Meban (1983)14 measured the BSA of fetuses or stil-
lborns ranging from 8–4080 g by directly covering skin
with aluminum foil or using skin dissection methods in
some fetuses14. Regardless of the small sample size and
little information on the characteristics of the samples,
the findings of that study were similar to the evaluation
of the suitability of Neo-BSA in this report since the two
measurements were derived from similar subjects. Neo-
-BSA was developed from 5014 high-risk newborns, rep-
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TABLE 4
VARIATION IN PERCENTILE OF BSA MEASUREMENTS COMPARED TO MEAN-BSA
GA
Boyd variation Dubois variation Meban variation Mosteller variation
F (p)
X (SD) X (SD) X (SD) X (SD)
24 –3.0 (1.13) –1.4 (0.76) 1.9 (0.17) –2.4 (0.35) 68.1667 (.000)
25 –3.7 (2.79) –0.5 (1.98) 1.5 (0.49) –2.6 (0.86) 26.2317 (.000)
26 –1.9 (4.71) –1.8 (3.94) 1.6 (0.99) –2.0 (1.40) 3.0886 (.039)
27 –1.4 (2.10) –1.9 (1.63) 1.4 (0.45) –1.9 (0.64) 29.8021 (.000)
28 –1.1 (2.62) –1.9 (2.02) 1.2 (0.42) –1.7 (0.81) 18.8141 (.000)
29 –0.1 (3.71) –2.5 (2.60) 1.1 (0.41) –1.4 (1.18) 9.6181 (.000)
30 –0.2 (2.05) –2.4 (1.55) 1.1 (0.40) –1.5 (0.63) 50.3366 (.000)
31 0.9 (2.38) –2.9 (1.74) 0.9 (0.33) –1.1 (0.75) 56.4372 (.000)
32 0.6 (2.05) –2.6 (1.60) 0.8 (0.35) –1.2 (0.63) 65.9024 (.000)
33 0.9 (2.36) –2.6 (1.74) 0.7 (0.29) –1.1 (0.73) 79.3982 (.000)
34 2.5 (1.98) –3.7 (1.53) 0.6 (0.29) –0.6 (0.62) 384.9441 (.000)
35 2.8 (2.11) –3.9 (1.51) 0.6 (0.23) –0.5 (0.67) 582.3440 (.000)
36 3.2 (1.79) –4.0 (1.33) 0.5 (0.23) –0.3 (0.57) 1884.137 (.000)
37 3.9 (1.83) –4.4 (1.34) 0.4 (0.20) –0.1 (0.59) 4796.08 (.000)
38 4.6 (1.69) –4.9 (1.25) 0.4 (0.19) 0.1 (0.54) 13015.12 (.000)
39 4.8 (1.63) –5.0 (1.23) 0.3 (0.17) 0.2 (0.52) 16121.91 (.000)
40 4.8 (1.63) –4.9 (1.24) 0.3 (0.19) 0.2 (0.52) 13392.09 (.000)
41 4.9 (1.80) –4.9 (1.35) 0.3 (0.17) 0.2 (0.58) 4163.54 (.000)
42 5.1 (1.35) –5.1 (1.01) 0.3 (0.15) 0.3 (0.43) 386.94 (.000)
Total 4.2 (2.20) –4.6 (1.49) 0.4 (0.28) –0.0 (0.71) 32681.23 (.000)
Variation in %; BSA in cm2
GA; gestational age; BSA: body surface area
TABLE 5
SIMILARITY AND DISSIMILARITY OF THE DEVELOPED NEO-BSA FORMULA TO OTHER FORMULAS
Boyd-BSA Dubois-BSA Meban-BSA Mosteller-BSA
Neo-BSA Correlation coefficient (p) .996 (.000) .996 (.000) 1 (.000) 1 (.000)
Euclidean distance 7066.0 7120.5 601.1 892.8
* p<.001
resenting almost the entire spectrum of newborns in
terms of birth weight and GA, of which some would share
comparable characteristics to those in the Meban (1983)
study. Therefore, it is likely that Neo-BSA and Meban-
-BSA mutually support the validity of each formula. In
particular, the validity of Neo-BSA compared to Meban-
-BSA is actually and theoretically acceptable, since direct
BSA measurement, laboratory wrapping or coating tech-
niques are no longer regarded as feasible and applicable
to infants.
Mosteller-BSA was found to be almost as good as
Meban-BSA, with a slightly larger Euclidian distance
(892.8), compared to Mean-BSA. Although the Mosteller
formula has provided very accurate estimates in healthy
newborns from Saudi Arabia18 and Korea11, special pre-
cautions are warranted when applying the Mosteller for-
mula to high-risk infants such as LBW infants, consider-
ing that the two studies just cited were performed on
healthy newborns with a mean weight of 2900–3254 g. In
particular, the Mosteller-BSA may overestimate the BSA
for individuals with a shorter body and bulkier limbs,
such as obese subjects19,20 and similar to newborns. The-
refore, general use of Mosteller-BSA is not appropriate,
pending more validation, regardless of its practical mer-
its of simplicity and ease of calculation for high-risk in-
fants.
On the other hand, the Boyd-BSA and Dubois-BSA
revealed substantial variations regardless of similarity of
patterns to Neo-BSA as evidenced by a high correlation
(r=.996) and large Euclidian distance (7066.022 and
7120.451) in BSA measurements of high-risk infants. An
interesting finding was observed in Boyd-BSA, where the
direction of variance was reversed at about 30 weeks GA,
resulting in an underestimation of BSA before 20–30
weeks GA, in contrast to overestimating BSA after 31
weeks GA. Overestimation of BSA by 5–12% has been re-
ported using the Boyd-BSA, where most subjects were
healthy newborns11,21. However, while little is reported
on BSA measurements in preterm births, this study
identified the underestimation of BSA by Boyd-BSA for
‘small preterm’ babies born before 29 weeks GA. It dem-
onstrated the largest variance of Boyd-BSA to Neo-BSA
(Figure 1). A comparable finding was identified in 2336
Korean school-age children in grades 4–6, in which the
Boyd-BSA produced the lowest BSA for thin children and
the highest BSA measurement for obese children among
the three BSA measurements, Boyd-BSA, Dubois-BSA
and Mosteller-BSA22. Considering the quite large sample
sizes in this and the above studies, the Boyd-BSA seems
to underestimate BSA for light and heavy subjects in pe-
diatric populations.
This phenomenon can be explained by the fact that
Boyd-BSA uses weight only. Since weight is the major de-
terminant of BSA rather than height, more variance in
BSA measurement could be calculated when variance co-
mes from weight. The overestimation or underestima-
tion by Boyd-BSA by the weight of infants may be ex-
plained by the mathematical function of the formula
itself using weight only. Therefore, caution is necessary
in using Boyd-BSA for infants, whether large or small in
size. For Boyd-BSA, having a higher surface-to-mass ra-
tio with relatively less importance of length may be ac-
ceptable in neonatal practice where height measurement
may not be available in high-risk infants.
Finally, Dubois-BSA demonstrated a maximum 5%
underestimation of BSA against Neo-BSA. The degree of
underestimation became greater as GA increased. Simi-
lar findings of BSA underestimations of 5–9% have been
reported in healthy newborns11,2,23 and 3–5% underesti-
mation in obese adults17. However, constant reports in
underestimation of Dubois-BSA including the present
finding, suggests the existence of systemic error in apply-
ing the Dubois formula to modern subjects, which was
developed from only nine individuals including just one
child almost one century ago13.
In the present study, the widest variance, about 10%
of the maximum deviation against the Mean- BSA, was
observed using Boyd-BSA and Dubois-BSA. The Boyd
formula using only weight has been acknowledged for pe-
diatric use, with modified guidelines for infants24. Mea-
surement of length may not be possible in every pediatric
instance5. The Dubois formula is popular as it is the basis
for the currently available BSA nomogram. However, the
present study’s findings raise a substantial concern about
applying these two formulas for high-risk infants.
In conclusion, this present study developed the Neo-
-BSA as a formula for high-risk infants, especially for
those in the 400–7000 g weight category. The Neo-BSA
formula has the clinical advantage of using only weight
(even though not as refined), considering that length as a
measurement is not usually feasible due to the high-risk
newborn’s body posture. This BSA scale identifies BSA
measurements based on weight only (Figure 4), so it can
be easily and quickly applied in clinical practice to high-
-risk infants. Neo-BSA may be the most suitable formula
for BSA measurement in high-risk infants in our modern
society, with new emerging advances in health sciences
and reproductive technologies that increase survival of
high-risk infant populations. Recent study supported a
developmental and clinical significance of investigation
on various physical parameters of these populations at a
very early stage of postnatal age25. Further studies are
required to confirm our findings with various popula-
tions and ethnic groups globally and under various clini-
cal conditions, particularly considering that physical pa-
rameters such as weight, height, and BSA at birth can
lead to further understanding on intrauterine growth
variation in relation to genetic and/or environmental in-
teractions.
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FORMULA I SKALA ZA PROCJENU TJELESNE POVR[INE KOD VISOKORIZI^NE DJECE
S A @ E T A K
Napredovanja u medicinskoj tehnologiji i zdravstvenim znanostima dovela su do rapidnog pove}anja u prevalenciji i
morbiditetu visokorizi~ne djece s kroni~nim ili stalnim posljedicama, kao {to je preuranjeno ro|enje dijeteta. Potrebna
je odgovaraju}a formula za procjenu visokorizi~ne djece preko tjelesne povr{ine (BSA) kako bi se to~nije odredili tera-
peutski re`imi u klini~koj praksi. Provedena je studija kohorte koja je uklju~ivala 5014 visokorizi~ne djece kako bi se
razvila odgovaraju}a formula za procjenu pomo}u BSA, koriste}i ~etiri postoje}e BSA jednad`be u literaturi. BSA kod
visokorizi~ne djece izra~unata je koriste}i ~etiri BSA jednad`be (Boyd-BSA, Budois-BSA, Meban-BSA, Mosteller-BSA),
nakon koje je nova ra~unica, Mean-BSA, aritmeti~ki izvu~ena kao referenca BSA mjere. Koristila se multipla regresija,
uz pomo} nelinearne krivulje najmanjeg kvadrata s obzirom na trend linije i nove jednad`be, koriste}i Neo-BSA koji je
razvijem uz pomo} programa Excell i SPSS 17.0. Neo-BSA jednad`ba konstruirana je ovako: Neo-BSA=5,520xW0,5526 ´
L0,3800. Uz pretpostavku odnosa korijena najmanjeg kvadrata izme|u te`ine i duljine, BSA skala, koja koristi samo
te`inu, proizvedena je specifi~no za klini~ku upotrebu, gdje je te`ina dostupnija u visokorizi~nim dje~jim populacijama
nego duljina. Valjanost Neo-BSA procijenjena je naspram Meban-BSA, najboljom od ~etiri jednad`be visokorizi~ne dje-
ce, budu}i da postoji sli~nost prou~avanih subjekata u ove dvije studije. Ostale formule otkrile su bitne varijance u BSA,
u usporedbi s Neo-BSA. Ovo istra`ivanje je razvilo novu jednad`bu tjelesne povr{ine, Neo-BSA, kao najbolje odgova-
raju}u formulu za mjerenje visokorizi~ne djece u suvremenim dru{tvima, gdje se brzorastu}oj populaciji novoro|en~adi
sa skra}enim gastacijskim periodom pove}ava prevalencija kao rezultat novih dostignu}a u zdravstvenim znanostima i
novim razvojima reproduktivne tehnologije. Specifi~no, skala od 400–7000 g tjelesne te`ine beba, koja je proiza{la iz
Neo-BSA jednad`be, ima klini~ku prednost koristiti samo te`inu kao mjeru, budu}i da duljina ~esto nije informativna
kao mjera zbog tjelesne postave novoro|en~eta. Daljnje studije trebale bi potvrditi na{e rezultate za kori{tenjem Neo-
-BSA i BSA skale (temeljene na te`ini) za razli~ite populacije i etnicitete uslijed razli~itih klini~kih uvjeta.
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